AMALGAMATED BANK - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$281
-17.6%
2,757
-26.6%
0.00%
-33.3%
Q1 2023$341
+110.5%
3,754
-11.9%
0.00%
+200.0%
Q4 2022$162
-99.8%
4,2630.0%0.00%0.0%
Q3 2022$107,000
-16.4%
4,263
+1.3%
0.00%0.0%
Q2 2022$128,000
-9.2%
4,207
-2.6%
0.00%0.0%
Q1 2022$141,000
-70.3%
4,318
-8.4%
0.00%
-75.0%
Q3 2021$474,000
-33.1%
4,715
-5.9%
0.00%
-33.3%
Q2 2021$709,000
+51.8%
5,011
+7.0%
0.01%
-66.7%
Q1 2021$467,000
-19.1%
4,684
+0.4%
0.02%
-18.2%
Q4 2020$577,000
+26.8%
4,664
-0.1%
0.02%
+10.0%
Q3 2020$455,000
-38.1%
4,668
-0.8%
0.02%
-41.2%
Q2 2020$735,000
+35.9%
4,708
+25.5%
0.03%
+161.5%
Q1 2020$541,000
-31.5%
3,750
-3.0%
0.01%
-13.3%
Q4 2019$790,000
+207.4%
3,866
+20.7%
0.02%
+200.0%
Q3 2019$257,000
-16.3%
3,203
-1.5%
0.01%
-28.6%
Q2 2019$307,000
+22.3%
3,253
+11.0%
0.01%
+16.7%
Q1 2019$251,0002,9310.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders